| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDGL | Common Stock | Options Exercise | $1M | +10K | +2.42% | $100.45 | 423K | May 14, 2024 | Direct | |
| transaction | MDGL | Common Stock | Options Exercise | $1.31M | +12.5K | +2.95% | $105.08 | 436K | May 14, 2024 | Direct | |
| transaction | MDGL | Common Stock | Sale | -$1.86M | -8.83K | -2.03% | $210.99 | 427K | May 14, 2024 | Direct | F1, F2 |
| transaction | MDGL | Common Stock | Sale | -$1.06M | -5.01K | -1.17% | $211.84 | 422K | May 14, 2024 | Direct | F1, F3 |
| transaction | MDGL | Common Stock | Sale | -$290K | -1.36K | -0.32% | $212.85 | 421K | May 14, 2024 | Direct | F1, F4 |
| transaction | MDGL | Common Stock | Sale | -$468K | -2.19K | -0.52% | $213.85 | 418K | May 14, 2024 | Direct | F1, F5 |
| transaction | MDGL | Common Stock | Sale | -$387K | -1.8K | -0.43% | $214.68 | 417K | May 14, 2024 | Direct | F1, F6 |
| transaction | MDGL | Common Stock | Sale | -$81K | -375 | -0.09% | $216.08 | 416K | May 14, 2024 | Direct | F1, F7 |
| transaction | MDGL | Common Stock | Sale | -$156K | -721 | -0.17% | $216.98 | 416K | May 14, 2024 | Direct | F1, F8 |
| transaction | MDGL | Common Stock | Sale | -$240K | -1.1K | -0.26% | $217.86 | 414K | May 14, 2024 | Direct | F1, F9 |
| transaction | MDGL | Common Stock | Sale | -$219K | -1K | -0.24% | $218.99 | 413K | May 14, 2024 | Direct | F1, F10 |
| transaction | MDGL | Common Stock | Sale | -$22K | -100 | -0.02% | $219.90 | 413K | May 14, 2024 | Direct | F1 |
| holding | MDGL | Common Stock | 1.26K | May 14, 2024 | See Footnotes | F11 | |||||
| holding | MDGL | Common Stock | 57.1K | May 14, 2024 | See Footnotes | F12 | |||||
| holding | MDGL | Common Stock | 18K | May 14, 2024 | See Footnotes | F13 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDGL | Stock Option (right to buy) | Options Exercise | $0 | -10K | -100% | $0.00* | 0 | May 14, 2024 | Common Stock | 10K | $100.45 | Direct | F14 |
| transaction | MDGL | Stock Option (right to buy) | Options Exercise | $0 | -12.5K | -100% | $0.00* | 0 | May 14, 2024 | Common Stock | 12.5K | $105.08 | Direct | F14 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2023. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.34 to $211.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.34 to $212.33, inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.36 to $213.31 inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.36 to $214.34 inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.39 to $215.27 inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.61 to $216.58 inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.61 to $217.23 inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.64 to $218.37 inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.68 to $219.34 inclusive. |
| F11 | These securities are held by Bay City Capital LLC ("BCC"). Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. |
| F12 | Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust. |
| F13 | Represents shares held indirectly by Dr. Craves through the Craves Family Foundation. |
| F14 | The shares underlying this stock option are fully vested. |
Exhibit 24 - Power of Attorney